跳至主要内容
临床试验/EUCTR2017-004038-28-BE
EUCTR2017-004038-28-BE进行中(未招募)1 期

Comparative Prospective Randomized Study in Postoperative Cardiac Surgery Patients on Analgesia with Morphine Continuous Infusion or Sublingual Sufentanil (Zalviso®).

niversitair Ziekenhuis Brussel0 个研究点目标入组 80 人开始时间: 2017年12月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All postoperative cardiac surgery patients aged between 18-75 y
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • -Patients with known allergy
  • -Patients with allergy to opioid drugs or a medical history of psychiatric disease --Patients with chronic inflammatory disease or chronic obstructive lung disease
  • -Pregnancy in female subjects in child-bearing age
  • -Body mass index greater than 35 kg/m2
  • -Participation in another clinical trial
  • -Drug abuse
  • -Psychological or emotional problems
  • -The use of nonsteroidal anti-inflammatory drugs or monoamine oxidase inhibitors
  • -Pain therapy with opioids 14 days before the start of the study
  • -Patients who are not cooperative or could not use PCA will be also excluded.
  • -All patients who cannot be weaned from the ventilator the day of surgery or the first postoperative day will be excluded
  • -Patients who are delirious or to whom no communication could be performed.

研究者

发起方
niversitair Ziekenhuis Brussel

相似试验